Autotransfusion Systems Market: By Product (Devices (Unwashed Autotransfusion System, Washed Autotransfusion System), Accessories), By Application (Cardiac surgery, Orthopedic surgery, Others), By End User (Hospitals, Clinics, Others) and Geography

Autotransfusion Systems Market size was estimated at USD 451.3 million in 2023 and is poised to grow at a CAGR of 5.8% from 2024-2030. Autotransfusion is the reinfusion of the patient's blood by collecting the blood from the thorax or peritoneal cavity after washing and antibiotic administration. In this process of autotransfusion, the patient receives their own blood for a transfusion instead of donor blood. There are several commercial devices available which perform autotransfusion, which are mainly three types of systems; un-washed filtered bloodstream, discontinuous flow centrifugal, and continuous flow centrifugal. The unwashed systems are popular because they are inexpensive. Whereas washed systems require a properly trained and clinically skilled operator.

Autotransfusion is particularly useful in case of blood loss during surgery and can eliminate the need for allogeneic blood. In December 2016, Fresenius Kabi and Terumo Cardiovascular Group have introduced their CATSmart autotransfusion system in the United States. The Autotransfusion Systems Market report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)